GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,225,516 | +14.6% | 165,670 | +37.5% | 0.05% | +20.5% |
| Q2 2023 | $7,175,404 | +5.4% | 120,514 | +0.3% | 0.04% | -2.2% |
| Q1 2023 | $6,805,466 | -24.0% | 120,153 | -0.4% | 0.04% | -28.6% |
| Q4 2022 | $8,955,477 | +23.6% | 120,580 | -0.8% | 0.06% | +18.9% |
| Q3 2022 | $7,243,000 | -1.5% | 121,588 | -7.2% | 0.05% | +6.0% |
| Q2 2022 | $7,356,000 | -25.5% | 131,035 | -2.1% | 0.05% | -7.4% |
| Q1 2022 | $9,880,000 | +2.4% | 133,907 | +0.2% | 0.05% | +12.5% |
| Q4 2021 | $9,653,000 | -6.6% | 133,694 | -0.9% | 0.05% | -12.7% |
| Q3 2021 | $10,334,000 | -3.3% | 134,878 | -2.2% | 0.06% | +52.8% |
| Q2 2021 | $10,690,000 | +23.8% | 137,883 | -1.5% | 0.04% | +20.0% |
| Q1 2021 | $8,636,000 | -3.7% | 140,035 | +1.8% | 0.03% | -9.1% |
| Q4 2020 | $8,972,000 | +31.2% | 137,563 | -0.4% | 0.03% | 0.0% |
| Q3 2020 | $6,836,000 | +1.4% | 138,052 | -2.3% | 0.03% | 0.0% |
| Q2 2020 | $6,744,000 | -18.2% | 141,349 | -27.1% | 0.03% | -26.7% |
| Q1 2020 | $8,245,000 | -28.2% | 193,866 | -0.6% | 0.04% | +2.3% |
| Q4 2019 | $11,479,000 | +15.9% | 194,961 | +0.6% | 0.04% | +10.0% |
| Q3 2019 | $9,908,000 | +19.1% | 193,809 | -1.5% | 0.04% | +21.2% |
| Q2 2019 | $8,319,000 | -14.9% | 196,675 | -0.6% | 0.03% | -10.8% |
| Q1 2019 | $9,780,000 | +12.2% | 197,941 | -1.7% | 0.04% | +2.8% |
| Q4 2018 | $8,719,000 | -21.6% | 201,448 | +2.8% | 0.04% | -2.7% |
| Q3 2018 | $11,119,000 | +14.3% | 195,893 | +1.6% | 0.04% | +8.8% |
| Q2 2018 | $9,730,000 | +3.6% | 192,822 | +2.2% | 0.03% | +3.0% |
| Q1 2018 | $9,396,000 | +16.6% | 188,603 | -3.8% | 0.03% | +26.9% |
| Q4 2017 | $8,056,000 | +39.0% | 195,998 | +0.5% | 0.03% | +30.0% |
| Q3 2017 | $5,796,000 | -7.9% | 195,018 | +2.7% | 0.02% | -9.1% |
| Q2 2017 | $6,293,000 | +15.3% | 189,846 | +3.0% | 0.02% | +10.0% |
| Q1 2017 | $5,460,000 | +24.3% | 184,342 | +4.2% | 0.02% | +17.6% |
| Q4 2016 | $4,391,000 | -99.5% | 176,980 | +338.1% | 0.02% | +325.0% |
| Q3 2016 | $911,851,000 | -5.1% | 40,401 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $961,278,000 | +0.7% | 40,339 | +0.4% | 0.00% | 0.0% |
| Q1 2016 | $955,000,000 | -14.6% | 40,198 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $1,118,000,000 | +134275.0% | 40,198 | -0.2% | 0.01% | +25.0% |
| Q3 2015 | $832,000 | -99.9% | 40,268 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $1,032,447,000 | -1.1% | 40,220 | -2.8% | 0.00% | 0.0% |
| Q1 2015 | $1,043,901,000 | +6.2% | 41,359 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $983,103,000 | +16.2% | 41,359 | -3.8% | 0.00% | 0.0% |
| Q3 2014 | $845,731,000 | -17.8% | 42,996 | -0.1% | 0.00% | -20.0% |
| Q2 2014 | $1,029,206,000 | +4.2% | 43,027 | +15.8% | 0.01% | 0.0% |
| Q1 2014 | $987,659,000 | +35.0% | 37,144 | +2.5% | 0.01% | +25.0% |
| Q4 2013 | $731,565,000 | +14.4% | 36,252 | -1.0% | 0.00% | +33.3% |
| Q3 2013 | $639,315,000 | +474.5% | 36,616 | +454.8% | 0.00% | +200.0% |
| Q2 2013 | $111,276,000 | – | 6,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |